Quest Diagnostics
DGX
#1046
Rank
โ‚น2.040 T
Marketcap
โ‚น18,343
Share price
-0.17%
Change (1 day)
22.80%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

Market capitalization of Quest Diagnostics (DGX)

Market cap: โ‚น2.040 Trillion

As of March 2026 Quest Diagnostics has a market cap of โ‚น2.040 Trillion. This makes Quest Diagnostics the world's 1046th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Quest Diagnostics from 1997 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น2.040 T15.53%
2025โ‚น1.766 T20.85%
2024โ‚น1.461 T13.24%
2023โ‚น1.290 T-12.46%
2022โ‚น1.474 T-6.67%
2021โ‚น1.579 T34.5%
2020โ‚น1.174 T15.97%
2019โ‚น1.012 T28.85%
2018โ‚น786.03 B-8.3%
2017โ‚น857.14 B-1%
2016โ‚น865.81 B28.07%
2015โ‚น676.04 B10.46%
2014โ‚น612.01 B28.49%
2013โ‚น476.30 B-5.71%
2012โ‚น505.14 B4.25%
2011โ‚น484.53 B17.36%
2010โ‚น412.86 B-19.6%
2009โ‚น513.51 B5.22%
2008โ‚น488.05 B21.09%
2007โ‚น403.06 B-11.47%
2006โ‚น455.27 B-0.97%
2005โ‚น459.74 B9.78%
2004โ‚น418.77 B22.36%
2003โ‚น342.23 B28.03%
2002โ‚น267.30 B-19.55%
2001โ‚น332.25 B7.72%
2000โ‚น308.44 B425.93%
1999โ‚น58.64 B157.83%
1998โ‚น22.74 B14.38%
1997โ‚น19.88 B

End of Day market cap according to different sources

On Mar 17th, 2026 the market cap of Quest Diagnostics was reported to be:

โ‚น2.015 Trillion
by Nasdaq info icon info icon
โ‚น2.040 Trillion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
LabCorp
LH
โ‚น2.071 T 1.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
โ‚น260.80 B-87.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Psychemedics
PMD
โ‚น1.45 B-99.93%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
โ‚น99.14 B-95.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
โ‚น790.59 B-61.25%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Enzo Biochem
ENZB
โ‚น3.37 B-99.83%๐Ÿ‡บ๐Ÿ‡ธ USA